BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
0.568
-0.020 (-3.40%)
Nov 21, 2024, 11:14 AM EST - Market open
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $23.14 million as of November 21, 2024. Its market cap has decreased by -83.49% in one year.
Market Cap
23.14M
Enterprise Value
71.31M
1-Year Change
-83.49%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $23.14M, a decrease of -86.59%. That is a compound annual growth rate of -25.89%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipocine | 25.46M |
| Athira Pharma | 24.94M |
| Ocean Biomedical | 24.90M |
| Equillium | 24.80M |
| DarioHealth | 24.75M |
| PolyPid | 24.49M |
| GlycoMimetics | 24.45M |
| Inspira Technologies Oxy B.H.N. | 23.68M |